Daron Ferris

5.4k total citations · 2 hit papers
46 papers, 3.5k citations indexed

About

Daron Ferris is a scholar working on Epidemiology, Surgery and Computer Vision and Pattern Recognition. According to data from OpenAlex, Daron Ferris has authored 46 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 13 papers in Surgery and 5 papers in Computer Vision and Pattern Recognition. Recurrent topics in Daron Ferris's work include Cervical Cancer and HPV Research (28 papers), Hepatitis B Virus Studies (12 papers) and Genital Health and Disease (10 papers). Daron Ferris is often cited by papers focused on Cervical Cancer and HPV Research (28 papers), Hepatitis B Virus Studies (12 papers) and Genital Health and Disease (10 papers). Daron Ferris collaborates with scholars based in United States, Mexico and Canada. Daron Ferris's co-authors include Scott Vuocolo, Richard M. Haupt, Edson Duarte Moreira, Stephen E. Goldstone, Anna R. Giuliano, Joel M. Palefsky, Richard J. Hillman, Heiko Jessen, Carlos Aranda and J. Brooke Marshall and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Daron Ferris

45 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

2011 821 citations Anna R. Giuliano, Joel M. Palefsky et al. New England Journal of Medicine profile →
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

2011 650 citations Joel M. Palefsky, Anna R. Giuliano et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Daron Ferris

Since Specialization

Citations

This map shows the geographic impact of Daron Ferris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daron Ferris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daron Ferris more than expected).

Fields of papers citing papers by Daron Ferris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daron Ferris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daron Ferris. The network helps show where Daron Ferris may publish in the future.

Co-authorship network of co-authors of Daron Ferris

This figure shows the co-authorship network connecting the top 25 collaborators of Daron Ferris. A scholar is included among the top collaborators of Daron Ferris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daron Ferris. Daron Ferris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up 2020 ·Papillomavirus Research ·(unknown), Jaime Alberto Restrepo, Julio C. Reina, Punnee Pitisuttithum, Àngels Ulied, Meera Varman, Pierre Van Damme, Edson Duarte Moreira, Daron Ferris, S. Block, Oliver Bautista, Nancy Gallagher, Jennifer McCauley, Alain Luxembourg	37
2	Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women 2017 ·Journal of Clinical Microbiology ·Jane R. Schwebke, Charlotte A. Gaydos, Thomas P. Davis, Jeanne Marrazzo, (unknown), Stephanie N. Taylor, (unknown), Laura H. Bachmann, Ronald Ackerman, (unknown), Daron Ferris, Carey‐Ann D. Burnham, Hilary Reno, (unknown), David L. Eisenberg, Peter R. Kerndt, Susan Philip, Jeanne A. Jordan, Neil B. Quigley	41
3	Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer 2013 ·PLoS ONE ·Jinhua Wang, Ashok Sharma, Sharad Ghamande, Stephen Bush, Daron Ferris, Wenbo Zhi, Ming‐Fang He, (unknown), Xiaoxiao Wang, Eric D. Miller, Diane Hopkins, Michael S. Macfee, Ruili Guan, Jinhai Tang, Jin‐Xiong She	11
4	Women’s Knowledge and Attitudes Toward Anal Pap Testing 2013 ·Journal of Lower Genital Tract Disease ·Daron Ferris, (unknown), Jennifer L. Waller, (unknown), (unknown), (unknown), Charlotte K. Steelman, (unknown)	11
5	Immune responses elicited by a fourth dose of the HPV-16/18 AS04-adjuvanted vaccine in previously vaccinated adult women 2012 ·Vaccine ·A.-B. Moscicki, Cosette M. Wheeler, Barbara Romanowski, James Hedrick, Stanley A. Gall, Daron Ferris, Sylviane Poncelet, Toufik Zahaf, Philippe Moris, Brecht Geeraerts, Dominique Descamps, Anne Schuind	26
6	End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age 2011 ·British Journal of Cancer ·Xavier Castellsagué, Núbia Muñóz, Punnee Pitisuttithum, Daron Ferris, Joseph Monsonégo, Kevin A. Ault, Joaquín Luna, Evan R. Myers, (unknown), Oliver Bautista, Janine T. Bryan, Scott Vuocolo, Richard M. Haupt, Alfred J. Saah	260
7	Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males breakdown → 2011 ·New England Journal of Medicine ·Anna R. Giuliano, Joel M. Palefsky, Stephen E. Goldstone, Edson Duarte Moreira, Mary E. Penny, Carlos Aranda, Eftyhia Vardas, Harald Moi, Heiko Jessen, Richard J. Hillman, Yen-Hwa Chang, Daron Ferris, Danielle Rouleau, Janine T. Bryan, J. Brooke Marshall, Scott Vuocolo, Eliav Barr, David Radley, Richard M. Haupt, Dalya Güriş	821
8	Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults 2011 ·Human Vaccines ·Edson Duarte Moreira, Joel M. Palefsky, Anna R. Giuliano, Stephen E. Goldstone, Carlos Aranda, Heiko Jessen, Richard J. Hillman, Daron Ferris, François Coutlée, Eftyhia Vardas, J. Brooke Marshall, Scott Vuocolo, Richard M. Haupt, Dalya Güriş, Elizabeth Garner	27
9	Parental Acceptance of a Mandatory Human Papillomavirus (HPV) Vaccination Program 2010 ·The Journal of the American Board of Family Medicine ·Daron Ferris, Lars‐Christian Horn, Jennifer L. Waller	25
10	Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment 2010 ·Addictive Behaviors ·Robert A. Schnoll, Elisa Martinez, (unknown), (unknown), Albert M. Bernath, Daron Ferris, Patrick Reynolds	77
11	Characterization of molecular markers indicative of cervical cancer progression 2009 ·PROTEOMICS - CLINICAL APPLICATIONS ·Hilal Arnouk, Mark A. Merkley, Robert H. Podolsky, Hubert Stöppler, Carlos Santos, Manuel Álvarez, (unknown), Daron Ferris, Jeffrey R. Lee, William S. Dynan	69
12	Evaluation of Quadrivalent HPV 6/11/16/18 Vaccine Efficacy Against Cervical Disease in Subjects with Prior Vaccine HPV Type Infection 2008 ·International Journal of Infectious Diseases ·Daron Ferris	3
13	Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis 2006 ·American Journal of Obstetrics and Gynecology ·Jack D. Sobel, Daron Ferris, Jane R. Schwebke, Paul Nyirjesy, Harold C. Wiesenfeld, Jeffrey F. Peipert, David E. Soper, Suzanne E. Ohmit, Sharon L. Hillier	204
14	Secure transmission of medical records using high capacity steganography 2004 ·(unknown), Brian Nutter, Suman K. Mitra, (unknown), Daron Ferris	14
15	Perforation Repair Comparing Two Types of Mineral Trioxide Aggregate 2004 ·Journal of Endodontics ·Daron Ferris, J BAUMGARTNER	97
16	Human Papillomavirus Vaccine Acceptability Among Parents of 10- to 15-Year-Old Adolescents 2004 ·Journal of Lower Genital Tract Disease ·Kristin Davis, Eileen D. Dickman, Daron Ferris, James K. Dias	291
17	Improving cervical cancer screening in Mexico: results from the Morelos HPV Study 2003 ·Salud Pública de México ·Yvonne N. Flóres, David Bishai, Eduardo Lazcano, Keerti V. Shah, Attila T. Lörincz, Mauricio Hernández, Jorge Salmerón, Daron Ferris, Pilar Hernández, Mark E. Sherman, Brigitte M. Ronnett, Enrique J. Carmona, (unknown), (unknown), (unknown), Ricardo Pérez‐Cuevas, Ahideé Leyva-López, Elsa Yunes	42
18	Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico 2003 ·Cancer Causes & Control ·Jorge Salmerón, Eduardo Lazcano‐Ponce, Attila T. Lörincz, Mauricio Hernández, Pilar Hernández, Ahideé Leyva-López, (unknown), (unknown), (unknown), Enrique J. Carmona, Brigitte M. Ronnett, Mark E. Sherman, David Bishai, Daron Ferris, Yvonne N. Flóres, Elsa Yunes, Keerti V. Shah	107
19	The Acceptability of Self-Collected Samples for HPV Testing vs. the Pap Test as Alternatives in Cervical Cancer Screening 2002 ·Journal of Women s Health & Gender-Based Medicine ·Ilana G. Dzuba, (unknown), Betania Allen, (unknown), Eduardo Lazcano‐Ponce, Keerti V. Shah, David Bishai, Attila T. Lörincz, Daron Ferris, Bernardo Turnbull, Mauricio Hernández Ávila, Jorge Salmerón	168
20	The efficacy of telecolposcopy compared with traditional colposcopy 2002 ·Obstetrics and Gynecology ·Daron Ferris	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact